September 21 (CNNBreakingNews.net) — The US Centers for Disease Control and Prevention assumes that COVID-19 vaccine boosters are Circulating variants of the virus will be available to children aged 5 to 11 years by mid-October
The CDC said in a document released Tuesday that it is expected to issue a recommendation to use the new bivalent vaccines in the group, provided they are approved by the US Food and Drug Administration (FDA). (https://bit.ly/3xFT5D0)
The vaccines, which both the original version and the variants of the virus currently in circulation, were released earlier this month for People introduced over 12 years of age.
The CDC expects the bivalent vaccine from Pfizer-BioNTech (PFE.N) to be available for children aged 5 to 11 years, and Modernas (MRNA. O) vaccine for people aged 6 to 17 years until FDA approval is obtained.
The Pfizer vaccine is already approved as a booster dose for children over 12 years of age, while Moderna is bivalent vaccine is for adults approved.
The CDC expects pre-orders for the Pfizer shot for the age group to begin next week. The Moderna vaccine will have the same formulation for children and adults and will not require a separate pre-order period, according to the CDC.
The United States government has ordered more than 170 million updated vaccine booster injections for this fall and further said on It had sent over 25 million cans on Tuesday. read more